Dencore and Serendex were chosen as the winner in the Lifesciences segment of the Nordic Venture 50. The most promising 50 companies were selected for the Nordic Venture 50 to present before an audience of Nordic and international venture capital, corporate investors and strategic partners. The base criterions for participation are;

  • Headquarters in the Nordic (Iceland, Norway, Denmark, Sweden, Finland) or Baltic (Estonia, Latvia, Lithuania) countries.
  • Active and innovative either in ICT, Lifesciences or Cleantech.
  • Seeking growth funding in the next 24 months.

The total list of winners in all segments are:

Company Profiles of all applicants were screened by one Advisory Board Member as well as two Expert Reviewers.

The selection process the ultimate winners were based on the following categories being evaluated:

  • Business potential – The potential market of customers for the presented product is attractive and the business model is strong
  • Team experience – Company team has skills and experience to grow the business and is able/willing to work with industry & research
  • Product / Technology merit – Technology or product solutions developed are state-of-the-art and well advanced compared to the competitors
  • Competitive position – The intellectual property of the company and its competences and strategic relations are outstanding
  • Investment or partnering interest – The demand/offer to invest in or partner with the company is well defined and potentially attractive for partners
  • Project profile quality – Information available from company profile sheet is complete, clear, balanced and convincing